Newsroom

Ciudad de México--(BUSINESS WIRE)--AM Best ha afirmado la Calificación de Fortaleza Financiera (FSR, por sus siglas en inglés) de B++ (Buena) y la Calificación Crediticia de Emisor (ICR, por sus siglas en inglés) de Largo Plazo de “bbb” (Buena) de Nacional de Seguros S.A. Compañía de Seguros Generales (Nacional de Seguros) (Bogotá, Colombia). La perspectiva de estas Calificaciones Crediticias (calificaciones) es estable. Las calificaciones de Nacional de Seguros reflejan la fortaleza de su bala...

MEXICO CITY--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of B++ (Good) and the Long-Term Issuer Credit Rating of “bbb” (Good) of Nacional de Seguros S.A. Compañía de Seguros Generales (Nacional de Seguros) (Bogota, Colombia). The outlook of these Credit Ratings (ratings) is stable. The ratings reflect Nacional de Seguros’ balance sheet strength, which AM Best assesses as very strong, as well as its adequate operating performance, limited business profile and appropriate...

SAN JOSE, Calif.--(BUSINESS WIRE)--Calix, Inc. (NYSE: CALX) today announced the launch of secure, private agents and agentic workflows at scale, with all 1,200+ customers live on the third-generation, AI-native Calix One™ platform, powered by Google Cloud. Delivered through Calix Agent Workforce Cloud, these capabilities span the full Calix portfolio, including Service Cloud, Engagement Cloud, and Operations Cloud—to optimize marketing, customer support, and network operations functions—and Sma...

PALO ALTO, Calif.--(BUSINESS WIRE)--Deepwatch today announced it has achieved ISO/IEC 42001:2023 certification, the international standard for artificial intelligence management systems (AIMS). The certification validates the company’s disciplined approach to developing, deploying, and managing its NEXA agents, underscoring its commitment to responsible AI governance. As AI rapidly reshapes the cybersecurity landscape, organizations face growing pressure to defend against increasingly sophistic...

BOSTON--(BUSINESS WIRE)--Eastern Bank is pleased to announce it has led the financing of Wood Partners’ Alta Altitude housing project, a 214-unit luxury, 100% market-rate apartment development in Warwick, RI. Eastern provided a $31 million construction loan for the project, which is located within the City of Warwick’s City Centre, a 95-acre Master Plan that calls for more than 1.5 million square feet of office, retail, hotel, commercial and residential space. The luxury property includes high-...

FOLSOM, Calif.--(BUSINESS WIRE)--Magnit Global™, the global leader in contingent workforce management solutions, today announced the upcoming completion of Magnit Gateway™, a supplier intelligence and integration platform that gives staffing suppliers the visibility, data, and AI-driven insights they need to compete more effectively within Magnit-managed programs. The Gateway API Toolkit has been live since March 2026; in mid-June, 2026, Magnit will complete the platform with the addition of th...

NEW YORK--(BUSINESS WIRE)--KBRA assigns a long-term rating of AAA to the State of Maryland General Obligation Bonds, State and Local Facilities Loan of 2026, First Series Tax-Exempt Bonds (Competitive) and affirms the long-term rating of AAA for the State's outstanding General Obligation Bonds. The rating Outlook is Stable. Key Credit Considerations The rating actions reflect the following key credit considerations: Credit Positives Inherent strength and breadth of the State GO payment pledge E...

BROOKLYN, N.Y.--(BUSINESS WIRE)--Values-based tech platform YourStake acquired First Affirmative, the pioneering RIA of the values-based advisor community; relaunching as Formative....

TEL AVIV, Israel & PARIS--(BUSINESS WIRE)--Regulatory News:  Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE: and TASE: TEVA) and Medincell (Euronext: MEDCL), today announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for olanzapine long-acting injectable (TEV-‘749) for the treatment of schizophrenia in adults. TEV-‘749 aims to address treatment adherence in real-world settings and contri...

TEL AVIV, Israël & PARIS--(BUSINESS WIRE)--Regulatory News :  Teva Pharmaceuticals International GmbH, filiale de Teva Pharmaceutical Industries Ltd. (NYSE et TASE : TEVA), et Medincell (Euronext : MEDCL), annoncent que l'Agence européenne des médicaments (EMA) a accepté le dossier de demande d’autorisation de mise sur le marché (AMM) de l’injection sous-cutanée à libération prolongée d’olanzapine (TEV-‘749) pour le traitement de la schizophrénie chez l’adulte. L’Olanzapine LAI est conçue pour...